Jio Platforms and Paras Healthcare are set to list on Oct. 28, and their unofficial grey-market GMP indicators are moving in very different directions. According to the reports, Jio Platforms is showing a much higher premium than Paras Healthcare, implying different expectations for their likely listing prices.

NDTV reports that Jio Platforms’ GMP is around the mid-$200s in rupee terms (roughly Rs 244 to Rs 248 across updates), while Paras Healthcare’s GMP is in the low teens (around Rs 11 to Rs 13). Using those GMP figures, one report estimates a Jio Platforms listing price in the low 1,300s (Rs 1,363), versus an estimate for Paras Healthcare in the mid-600s (Rs 704). The articles present the same core comparison—GMP levels, their implied listing-price estimates, and the relative “listing gain potential”—but vary in how they frame the comparison and which GMP snapshot they foreground.